This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

19 Mar 2012

Merck to Invest $90M in New Drug Research Center

Merck will provide the California Institute for Biomedical Research $90 million over seven years to advance drug discoveries.

Merck & Co. is to launch the California Institute for Biomedical Research (Calibr) in La Jolla, CA, to advance discoveries into new drugs.


Merck will provide the new nonprofit institute $90 million over seven years. In return, it will hold options to obtain exclusive commercial licenses to any proteins or small molecule therapeutic candidates resulting from Calibr research.


At Calibr, research will progress to preclinical proof of concept, at which stage commercial partnerships will be sought for further development. The incubator will occupy about 50,000 square feet and be equipped for programs in immunology, autoimmune and metabolic disorders, cardiovascular disease, regenerative medicine, cancer biology, and neurodegenerative disease.

Related News